Over the past 12 months, 5 insiders at Verrica Pharmaceuticals Inc. filed 6 open-market SEC Form 4 transactions on VRCA: 6 purchases worth $18.0M and 0 sales worth $0. Insiders have been net buyers over this period. The most recent filing was on Nov 25, 25.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 25, 25 | John J. KirbyInterim CFO | BUY | 3.5K | $4.24 | $15K |
| Nov 25, 25 | Paul B ManningDirector,TenPercentOwner | BUY | 2.75M | $4.24 | $11.7M |
| Nov 25, 25 | Jayson RiegerCEO and President | BUY | 94.3K | $4.24 | $400K |
| Nov 25, 25 | Noah L. RosenbergCMO | BUY | 2.4K | $4.24 | $10K |
| Nov 25, 25 | David ZawitzChief Operating Officer | BUY | 10.0K | $4.24 | $42K |
| Mar 17, 25 | Christopher G. HayesCHIEF LEGAL OFFICER | SELL | 4.3K | $0.65 | $3K |
| Nov 22, 24 | Paul B ManningDirector,TenPercentOwner | BUY | 18.43M | - | $0 |
| Nov 22, 24 | Jayson RiegerCEO and President | BUY | 280.9K | - | $0 |
| Nov 22, 24 | John A Stalfort IIIDirector | BUY | 1.12M | - | $0 |
| Aug 27, 24 | Joe BonaccorsoCHIEF COMMERCIAL OFFICER | SELL | 9.0K | $2.46 | $22K |
| Aug 27, 24 | Gary GoldenbergChief Medical Officer | SELL | 3.6K | $2.46 | $9K |
| Aug 27, 24 | Christopher G. HayesCHIEF LEGAL OFFICER | SELL | 9.5K | $2.46 | $23K |
| Aug 27, 24 | Terry KohlerCHIEF FINANCIAL OFFICER | SELL | 7.9K | $2.46 | $19K |
| Aug 27, 24 | Ted WhitePRESIDENT AND CEO | SELL | 9.0K | $2.46 | $22K |
| Aug 26, 24 | Joe BonaccorsoCHIEF COMMERCIAL OFFICER | SELL | 24.7K | $2.66 | $66K |
| Aug 26, 24 | Gary GoldenbergChief Medical Officer | SELL | 9.9K | $2.66 | $26K |
| Aug 26, 24 | Christopher G. HayesCHIEF LEGAL OFFICER | SELL | 26.2K | $2.66 | $70K |
| Aug 26, 24 | Terry KohlerCHIEF FINANCIAL OFFICER | SELL | 21.8K | $2.66 | $58K |
| Aug 26, 24 | Ted WhitePRESIDENT AND CEO | SELL | 25.0K | $2.66 | $66K |
| Jul 23, 24 | Joe BonaccorsoCHIEF COMMERCIAL OFFICER | SELL | 115 | $6.98 | $803 |
| Jul 23, 24 | Gary GoldenbergChief Medical Officer | SELL | 86 | $6.98 | $600 |
| Jul 23, 24 | Christopher G. HayesCHIEF LEGAL OFFICER | SELL | 91 | $6.98 | $635 |
| Jul 23, 24 | Ted WhitePRESIDENT AND CEO | SELL | 154 | $6.98 | $1K |
| Jul 22, 24 | Joe BonaccorsoCHIEF COMMERCIAL OFFICER | SELL | 25.5K | $7.06 | $180K |
| Jul 22, 24 | Gary GoldenbergChief Medical Officer | SELL | 18.4K | $7.06 | $130K |
| Jul 22, 24 | Christopher G. HayesCHIEF LEGAL OFFICER | SELL | 21.6K | $7.06 | $153K |
| Jul 22, 24 | Ted WhitePRESIDENT AND CEO | SELL | 32.5K | $7.06 | $229K |
| Dec 29, 23 | Joseph EdelmanTenPercentOwner | BUY | 115.8K | $7.24 | $838K |
| Dec 28, 23 | Joseph EdelmanTenPercentOwner | BUY | 126.1K | $7.08 | $893K |
| Dec 27, 23 | Joseph EdelmanTenPercentOwner | BUY | 79.7K | $7.20 | $574K |
| Dec 26, 23 | Perceptive Advisors LlcTenPercentOwner | BUY | 54.7K | $6.49 | $355K |
| Dec 22, 23 | Perceptive Advisors LlcTenPercentOwner | BUY | 250.0K | $6.67 | $1.7M |
| Dec 21, 23 | Perceptive Advisors LlcTenPercentOwner | BUY | 200.0K | $6.17 | $1.2M |
| Dec 19, 23 | Perceptive Advisors LlcTenPercentOwner | BUY | 277.0K | $5.36 | $1.5M |
| Dec 18, 23 | Perceptive Advisors LlcTenPercentOwner | BUY | 456.9K | $5.41 | $2.5M |
| Dec 15, 23 | Perceptive Advisors LlcTenPercentOwner | BUY | 500.0K | $5.97 | $3.0M |
| Nov 15, 23 | Joe BonaccorsoChief Commercial Officer | SELL | 11.3K | $2.97 | $33K |
| Nov 15, 23 | Gary GoldenbergChief Medical Officer | SELL | 3.0K | $2.97 | $9K |
| Nov 15, 23 | Christopher G. HayesChief Legal Officer | SELL | 11.6K | $2.97 | $34K |
| Nov 15, 23 | Terry KohlerChief Financial Officer | SELL | 9.6K | $2.97 | $29K |
| Nov 15, 23 | Ted WhitePresident and CEO | SELL | 11.6K | $2.97 | $34K |
| Nov 14, 23 | Joe BonaccorsoChief Commercial Officer | SELL | 21.6K | $2.93 | $63K |
| Nov 14, 23 | Gary GoldenbergChief Medical Officer | SELL | 5.8K | $2.93 | $17K |
| Nov 14, 23 | Christopher G. HayesChief Legal Officer | SELL | 22.1K | $2.93 | $65K |
| Nov 14, 23 | Terry KohlerChief Financial Officer | SELL | 18.5K | $2.93 | $54K |
| Nov 14, 23 | Ted WhitePresident and CEO | SELL | 22.1K | $2.93 | $65K |
| Jul 24, 23 | Paul B ManningDirector,TenPercentOwner | BUY | 200.0K | $5.02 | $1.0M |
| Jul 24, 23 | Joe BonaccorsoChief Commercial Officer | SELL | 38.3K | $4.83 | $185K |
| Jul 24, 23 | Gary GoldenbergChief Medical Officer | SELL | 28.7K | $4.83 | $139K |
| Jul 24, 23 | Christopher G. HayesChief Legal Officer | SELL | 33.8K | $4.83 | $163K |
Over the past 12 months, insiders at Verrica Pharmaceuticals Inc. filed 6 open-market purchases worth $18.0M and 0 sales worth $0 on VRCA, which makes them net buyers over the period. The most recent Form 4 was filed on Nov 25, 25.
The largest recent open-market VRCA insider purchase in our data was $11.7M by Paul B Manning, Director,TenPercentOwner, filed on Nov 25, 25.
5 different insiders at Verrica Pharmaceuticals Inc. filed open-market SEC Form 4 transactions on VRCA over the last 12 months.
InsiderTape plots every VRCA insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Verrica Pharmaceuticals Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →